AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer

Papillary thyroid carcinomas (PTCs) have an excellent prognosis, but a fraction of them show aggressive behavior, becoming radioiodine (RAI)-resistant and/or metastatic. AXL (Anexelekto) is a tyrosine kinase receptor regulating viability, invasiveness and chemoresistance in various human cancers, in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Collina, Francesca, La Sala, Lucia, Liotti, Federica, Prevete, Nella, La Mantia, Elvira, Chiofalo, Maria Grazia, Aquino, Gabriella, Arenare, Laura, Cantile, Monica, Liguori, Giuseppina, Di Gennaro, Francesca, Pezzullo, Luciano, Losito, Nunzia Simona, Vecchio, Giancarlo, Botti, Gerardo, Melillo, Rosa Marina, Franco, Renato
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6628138/
https://ncbi.nlm.nih.gov/pubmed/31181609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11060785
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge